Published in J Hepatol on February 04, 2010
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol (2013) 1.15
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure. J Gastroenterol (2012) 0.84
The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation. J Korean Med Sci (2013) 0.81
Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences. PLoS One (2015) 0.80
Renal dysfunction in patients with cirrhosis: Where do we stand? World J Gastrointest Pharmacol Ther (2014) 0.80
Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases. Oncol Lett (2016) 0.79
Gender-based disparities in access to and outcomes of liver transplantation. World J Hepatol (2015) 0.78
Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol (2014) 0.78
Evaluation of renal function in patients with cirrhosis: where are we now? World J Gastroenterol (2014) 0.78
Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol (2012) 0.77
Acute renal injury after partial hepatectomy. World J Hepatol (2016) 0.75
Renal function and MELD: being direct is better. J Hepatol (2010) 0.75
Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia. Ann Gastroenterol (2012) 0.75
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med (2006) 10.63
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl (2005) 4.46
Electrolyte and circulatory changes in terminal liver failure. Lancet (1956) 3.51
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology (2004) 3.45
The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology (1993) 3.28
Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis (2004) 3.11
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut (2007) 2.09
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology (2006) 1.93
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology (1988) 1.76
Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis (2003) 1.74
Chronic renal dysfunction late after liver transplantation. Liver Transpl (2002) 1.74
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology (2008) 1.70
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med (1994) 1.65
Formula estimation of glomerular filtration rate: have we gone wrong? BMJ (2007) 1.61
GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis (1997) 1.54
A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol (2001) 1.49
Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology (2001) 1.29
Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit (1983) 1.24
Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl (2002) 1.12
Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl (2005) 1.11
A simple technique for estimating glomerular filtration rate with subcutaneous injection of (125I)lothalamate. Mayo Clin Proc (1975) 1.07
Low serum creatinine levels in severe hepatic disease. Arch Intern Med (1988) 1.02
Renal function--estimation of glomerular filtration rate. Clin Chem Lab Med (2006) 1.00
A prognostic model for patients with end-stage liver disease. Gastroenterology (1997) 0.99
Prognostic significance of renal dysfunction in cirrhosis. Kidney Int Suppl (1997) 0.86
Glomerular filtration rate measurement in cirrhotic patients with renal failure. Clin Nephrol (1998) 0.83
Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. J Hepatol (2004) 0.82
Nutritional support during liver failure. Crit Care Clin (1995) 0.81
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc (2003) 9.96
A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med (2002) 8.63
Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med (2006) 7.24
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med (2007) 6.07
Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med (2013) 5.19
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet (2010) 4.75
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood (2005) 4.48
Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl (2005) 4.46
POEMS syndrome: definitions and long-term outcome. Blood (2002) 4.35
The Budd-Chiari syndrome. N Engl J Med (2004) 3.95
Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum (2010) 3.84
Acute-on chronic liver failure. J Hepatol (2012) 3.74
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol (2004) 3.43
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology (2003) 3.22
Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis (2004) 3.11
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood (2004) 2.97
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology (2003) 2.89
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood (2007) 2.87
Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol (2011) 2.74
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood (2003) 2.68
Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc (2004) 2.62
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Serum aminotransferase activity and mortality risk in a United States community. Hepatology (2008) 2.61
Survival differences following lung transplantation among US transplant centers. JAMA (2010) 2.57
Splanchnic artery aneurysms. Mayo Clin Proc (2007) 2.55
Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis (2010) 2.54
Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol (2011) 2.47
Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology (2012) 2.44
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation (2007) 2.43
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc (2004) 2.43
Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc (2006) 2.37
Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology (2007) 2.36
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) (2006) 2.34
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology (2012) 2.33
Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics (2004) 2.31
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer (2004) 2.31
Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology (2014) 2.27
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer (2014) 2.26
Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology (2008) 2.26
The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum (2007) 2.25
Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology (2006) 2.25
Sudden death after myocardial infarction. JAMA (2008) 2.24
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23
Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation (2004) 2.22
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum (2008) 2.14
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis (2008) 2.12
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
Mesenteric venous thrombosis. Mayo Clin Proc (2013) 2.09
Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res (2008) 2.07
The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med (2010) 2.06
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology (2013) 2.03
A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology (2008) 2.02
Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol (2008) 2.02
Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc (2007) 2.01
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis (2011) 2.01
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology (2011) 1.99
Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood (2006) 1.98
Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet (2004) 1.96
MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl (2007) 1.94
The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum (2008) 1.94
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care (2006) 1.93
Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology (2006) 1.93
Performance standards for therapeutic abdominal paracentesis. Hepatology (2004) 1.93
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum (2011) 1.91
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood (2009) 1.90
Autoantibodies and the risk of cardiovascular events. J Rheumatol (2009) 1.89
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc (2009) 1.88
Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant (2004) 1.87